剰余金の配当（中間配当）、有価証券及び投資有価証券の取得による支出、売上収益（IFRS）他2件
- 【期間】
| 年度 | 剰余金の配当（中間配当） | 有価証券及び投資有価証券の取得による支出 | 売上収益（IFRS） | 全事業営業利益又は全事業営業損失（△） - 医薬・バイオケミカル | 構築物 |
|---|
| 2008/12 | - | | -21.4億 | | - | | - | | 68億 | |
| 2009/12 | - | | -1373億 | 赤拡 | - | | - | | 70億 | +3% |
| 2010/03 | - | | -3.08億 | 赤縮 | - | | - | | - | |
| 2010/06 | - | | -3.83億 | 赤拡 | - | | - | | - | |
| 2010/09 | - | | -865億 | 赤拡 | - | | - | | - | |
| 2010/12 | - | | -870億 | 赤拡 | - | | - | | 58.3億 | -16.7% |
| 2011/03 | - | | -81.9億 | 赤縮 | - | | - | | - | |
| 2011/06 | - | | -43.4億 | 赤縮 | - | | - | | - | |
| 2011/09 | - | | -2464億 | 赤拡 | - | | - | | - | |
| 2011/12 | -130億 | | -443億 | 赤縮 | - | | - | | 47.7億 | -18.1% |
| 2012/06 | - | | -46.1億 | 赤縮 | - | | - | | - | |
| 2012/12 | -130億 | 赤縮 | -96.4億 | 赤拡 | - | | 555億 | | 44.7億 | -6.4% |
| 2013/03 | - | | - | | - | | - | | - | |
| 2013/06 | - | | -24.6億 | 赤縮 | - | | - | | - | |
| 2013/09 | - | | - | | - | | - | | - | |
| 2013/12 | - | | -44.2億 | 赤拡 | - | | 543億 | -2.1% | 35.9億 | -19.7% |
| 2014/03 | - | | - | | - | | - | | - | |
| 2014/06 | - | | -81.5億 | 赤拡 | - | | - | | - | |
| 2014/09 | - | | - | | - | | - | | - | |
| 2014/12 | - | | -267億 | 赤拡 | - | | 389億 | -28.5% | - | |
| 2015/03 | - | | - | | - | | - | | - | |
| 2015/06 | - | | -57.4億 | 赤縮 | - | | - | | - | |
| 2015/09 | - | | - | | - | | - | | - | |
| 2015/12 | - | | -107億 | 赤拡 | - | | 468億 | +20.4% | - | |
| 2016/03 | - | | - | | - | | - | | - | |
| 2016/06 | - | | -55.4億 | 赤縮 | - | | - | | - | |
| 2016/09 | - | | - | | - | | - | | - | |
| 2016/12 | - | | -208億 | 赤拡 | - | | 347億 | -25.8% | - | |
| 2017/03 | - | | - | | - | | - | | - | |
| 2017/06 | - | | -109億 | 赤縮 | - | | - | | - | |
| 2017/09 | - | | - | | - | | - | | - | |
| 2018/12 | - | | - | | 1.93兆 | | - | | - | |
| 2019/03 | - | | - | | 0.43兆 | -77.5% | - | | - | |
| 2019/06 | - | | - | | 0.93兆 | +114.1% | - | | - | |
| 2019/09 | - | | - | | 1.44兆 | +54.6% | - | | - | |
| 2019/12 | - | | - | | 1.94兆 | +35% | - | | - | |
| 2020/03 | - | | - | | 0.42兆 | -78.1% | - | | - | |
| 2020/06 | - | | - | | 0.87兆 | +105.5% | - | | - | |
| 2020/09 | - | | - | | 1.36兆 | +55.8% | - | | - | |
| 2020/12 | - | | - | | 1.85兆 | +36% | - | | - | |
| 2021/03 | - | | - | | 0.41兆 | -77.9% | - | | - | |
| 2021/06 | - | | - | | 0.86兆 | +111.1% | - | | - | |
| 2021/09 | - | | - | | 1.33兆 | +53.5% | - | | - | |
| 2021/12 | - | | - | | 1.82兆 | +37.3% | - | | - | |
| 2022/03 | - | | - | | 0.42兆 | -77.1% | - | | - | |
| 2022/06 | - | | - | | 0.92兆 | +120.1% | - | | - | |
| 2022/09 | - | | - | | 1.46兆 | +58.9% | - | | - | |
| 2022/12 | - | | - | | 1.99兆 | +36.5% | - | | - | |
| 2023/03 | - | | - | | 0.45兆 | -77.4% | - | | - | |
| 2023/06 | - | | - | | 0.97兆 | +115.4% | - | | - | |
| 2023/09 | - | | - | | 1.55兆 | +59.5% | - | | - | |
| 2023/12 | - | | - | | 2.13兆 | +37.9% | - | | - | |
| 2024/03 | - | | - | | 0.5兆 | -76.5% | - | | - | |
